Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 58 citing articles:

Critical Review of Plant-Derived Compounds as Possible Inhibitors of SARS-CoV-2 Proteases: A Comparison with Experimentally Validated Molecules
Yasel Guerra, Diana Celi, Paúl Cueva, et al.
ACS Omega (2022) Vol. 7, Iss. 49, pp. 44542-44555
Open Access | Times Cited: 8
Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses
Brendan T. Freitas, Daniil A. Ahiadorme, Rahul S. Bagul, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 3, pp. 596-611
Open Access | Times Cited: 7
Chemical Reactivity and Optical and Pharmacokinetics Studies of 14 Multikinase Inhibitors and Their Docking Interactions Toward ACK1 for Precision Oncology
Ruby Srivastava
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 7
Plant-derived active compounds as a potential nucleocapsid protein inhibitor of SARS-CoV-2: anin-silicostudy
Dharmendra Kashyap, Rajarshi Roy, Parimal Kar, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 10, pp. 4770-4785
Closed Access | Times Cited: 7
Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19
Hong Liang, Min He, Shaoping Li, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 7
A Review of In Silico Research, SARS-CoV-2, and Neurodegeneration: Focus on Papain-Like Protease
Alessandra Schmitt Rieder, Bruna Ferrary Deniz, Carlos Alexandre Netto, et al.
Neurotoxicity Research (2022) Vol. 40, Iss. 5, pp. 1553-1569
Open Access | Times Cited: 6
Evaluation of the anti-diabetic drug sitagliptin as a novel attenuate to SARS-CoV-2 evidence-based in silico: molecular docking and molecular dynamics
José Ednésio da Cruz Freire, José Edvar Monteiro Júnior, Daniel Pascoalino Pinheiro, et al.
3 Biotech (2022) Vol. 12, Iss. 12
Open Access | Times Cited: 6
The Potential of Anti-coronavirus Plant Secondary Metabolites in COVID-19 Drug Discovery as an Alternative to Repurposed Drugs: A Review
Zahra Alipour, Somayeh Zarezadeh, Ali Akbar Ghotbi-Ravandi
Planta Medica (2023) Vol. 90, Iss. 03, pp. 172-203
Closed Access | Times Cited: 3
Can propolis and their compounds be efficacy in the treatment of coronavirus disease 2019 (COVID-19)? A systematic review
Rilcy Carla Silva Sobrinho, Ivani Rosa de Meneses, Bruna Cristina Alves, et al.
Research Society and Development (2022) Vol. 11, Iss. 8, pp. e3411830302-e3411830302
Open Access | Times Cited: 5
Staying Ahead of the Game: How SARS-CoV-2 has Accelerated the Application of Machine Learning in Pandemic Management
Alexander H. Williams, Chang‐Guo Zhan
BioDrugs (2023) Vol. 37, Iss. 5, pp. 649-674
Closed Access | Times Cited: 2
In silico investigation to identify potential small molecule inhibitors of the RNA-dependent RNA polymerase (RdRp) nidovirus RdRp-associated nucleotidyltransferase domain
Eleni Pitsillou, Julia Liang, Helen Yu Meng Huang, et al.
Chemical Physics Letters (2021) Vol. 779, pp. 138889-138889
Open Access | Times Cited: 5
Antioxidant capacity of snack cookies made from mango and pineapple fermentation
Ronald Rompies, Nelly Mayulu, Fahrul Nurkolis, et al.
Food Research (2021) Vol. 5, Iss. 5, pp. 145-148
Open Access | Times Cited: 5

Zahra Alipour, Somayeh Zarezadeh, Ali Akbar Ghotbi-Ravandi
Planta Medica (2024) Vol. 90, Iss. 03
Open Access
Utilization of the EpiMed Coronabank Chemical Collection to identify potential SARS-CoV-2 antivirals: in silico studies targeting the nsp14 ExoN domain and PLpro naphthalene binding site
Julia Liang, Eleni Pitsillou, Hannah L.Y. Lau, et al.
Journal of Molecular Graphics and Modelling (2024) Vol. 131, pp. 108803-108803
Open Access
Exploring potential therapeutic candidates against COVID-19: a molecular docking study
S M Taiabul Haque, Sukanta Bhadra, Nishith Kumar Pal
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access
Molecular insights into natural product compounds targeting papain protease of SARS-CoV-2 through molecular dynamics simulation
Chananya Rajchakom, Nitchakan Darai, Thitiya Boonma, et al.
Monatshefte für Chemie - Chemical Monthly (2024)
Closed Access
Flavonoids as Auxiliary Means in the Therapy and Prevention of COVID-19: Part II. Potential Targets
Ya. F. Zverev, A. Ya. Rykunova
Applied Biochemistry and Microbiology (2024) Vol. 60, Iss. 9, pp. 1674-1693
Closed Access
Antimicrobial polyhydroxybutyrate submicron fiber mat loaded with extract of Hypericum perforatum
M. Beran, Aleš Horna, Viktor Voříšek, et al.
Journal of Plant Biotechnology (2022) Vol. 49, Iss. 3, pp. 257-270
Open Access | Times Cited: 3
In Silico Analysis of the Antidepressant Fluoxetine and Related Drugs at SARS-CoV-2 Main Protease (Mpro) and Papain-like Protease (PLpro)
João Batista Teixeira da Rocha, Pedro José Tronco Pauletto, Folorunsho Bright Omage, et al.
Current Drug Discovery Technologies (2022) Vol. 20, Iss. 2
Closed Access | Times Cited: 3
Modeling and Study of Anti-coronavirus Activity of 6,7-Dimethoxyquinazoline-4(3H)-one Derivatives in Relation to SARS-COV-2 by in silico and in vitro Methods
A. Chiriapkin, I. N. Tyurenkov, И. П. Кодониди, et al.
Bulletin of Science and Practice (2023), Iss. 8, pp. 58-68
Open Access | Times Cited: 1
Anthocyanins as Immunomodulatory Dietary Supplements: A Nutraceutical Perspective and Micro-/Nano-Strategies for Enhanced Bioavailability
Thadiyan Parambil Ijinu, Lorenza Francesca De Lellis, Santny Shanmugarama, et al.
(2023)
Open Access | Times Cited: 1
Phytochemical-loaded Nanoparticles in COVID-19 Management
Suneetha Vuppu, Toshika Mishra, Shatakshi Mishra, et al.
Natural Resources for Human Health (2023) Vol. 4, Iss. 1, pp. 51-72
Open Access | Times Cited: 1
Potential Molecules Against Covid-19 from Annona muricata; an in-silico Approach
Miftahul Mushlih
Medical Technology and Public Health Journal (2022) Vol. 06, Iss. 01, pp. 11-20
Open Access | Times Cited: 2
The current state of validated small molecules inhibiting SARS-CoV-2 nonstructural proteins
Fatih Kocabaş, Merve Uslu
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 469-483
Open Access | Times Cited: 2
Exploiting the glycan receptor-binding site of PltB subunit in salmonella typhi toxin for novel inhibitors: An in-silico approach
Ephraim Felix Marondedze, Penny P. Govender
Journal of Molecular Graphics and Modelling (2021) Vol. 111, pp. 108082-108082
Closed Access | Times Cited: 2

Scroll to top